Iodine123IoflupaneQualityChecker

Iodine-123 Ioflupane

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity PET
Open selection

Utility description: Iodine-123 Ioflupane

Iodine-123 Ioflupane Quality Checker — Ioflupane I-123 (DaTscan®)

ℹ️  Utility checks critical parameters of the radiopharmaceutical for dopamine transporter imaging:
    • Radiochemical purity (≥95%)
    • Free Iodine-123 impurity (≤5%)
    • Radionuclidic impurity Iodine-124 (≤0.3%) — CRITICAL!
    • Radionuclidic impurity Iodine-125 (≤0.1%)
    • Specific activity (≥100 GBq/μmol)
    • pH, endotoxins, sterility, residual ethanol

⚠️  CRITICAL: I-124 impurity >0.3% is unacceptable! I-124 emits positrons and high-energy gamma rays, significantly increasing patient dose and degrading image quality (noise).
    Free iodine accumulates in the thyroid and stomach, creating artifacts.

Usage:
  Iodine123IoflupaneQualityChecker.exe                            → demo mode (console output)
  Iodine123IoflupaneQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore

Example (sterility: 0=sterile, 1=contaminated, appearance: 0=normal):
  I123-IOF-2026-001,98.5,1.0,0.1,0.05,150.0,7.0,40.0,0,5.0,0

— WHY IS THIS NEEDED?
Ioflupane I-123 (DaTscan®) is used for diagnosing Parkinson's disease and other parkinsonian syndromes.
• I-123 (T½=13.2 hours) binds to presynaptic dopamine transporters (DAT) in the striatum.
• Allows differentiation of neurodegenerative parkinsonism (reduced uptake) from essential tremor (normal uptake).

⚠️  CRITICAL:
• Radiochemical purity ≥95% — ensures specific binding to DAT.
• Free Iodine-123 ≤5% — requires thyroid blocking with potassium iodide prior to administration if impurity is high.
• I-124 impurity ≤0.3% — I-124 (T½=4.18 days) has high positron yield, increasing dose and creating noise.
• Specific activity ≥100 GBq/μmol — necessary to prevent cold ligand from competing for receptors, which would weaken the signal.
• pH 6.0–8.0 — physiological compatibility.
• Ethanol ≤10% — solvent for the hydrophobic ligand.

Key features:
• Strict control of radionuclidic impurities (I-124/I-125) characteristic of cyclotron-produced I-123.
• Specific activity control to prevent receptor saturation.
• Appearance check (clarity/color) as the product is light-sensitive.

Critical parameters:
• Radiochemical purity: ≥95.0%
• Free Iodine-123: ≤5.0%
• I-124 impurity: ≤0.3%
• I-125 impurity: ≤0.1%
• Specific activity: ≥100 GBq/μmol
• pH: 6.0–8.0
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Ethanol: ≤10.0%

💡 Usage tips:
1. RCP is controlled by HPLC or TLC.
2. Radionuclidic purity is determined by gamma spectrometry (I-124 peaks: 602 keV, 1691 keV; I-123: 159 keV).
3. Patients must be prescribed perchlorate or potassium iodide 1 hour before injection to block the thyroid.
4. Protect the product from light (photosensitive).

⚠️ Note: Production of I-123 is often accompanied by the formation of I-124 via the (p,2n) reaction on tellurium-124 if proton energy is too high. Control of I-124 is a marker of cyclotron irradiation quality.

input.csv

BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore
I123-IOF-2026-001,98.5,1.0,0.1,0.05,150.0,7.0,40.0,0,5.0,0
I123-IOF-2026-002,94.0,4.0,0.5,0.08,120.0,7.2,50.0,0,6.0,0

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Iodine123IoflupaneQualityChecker for Iodine-123 Ioflupane.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of the radiopharmaceutical for dopamine transporter imaging:
  • • Radiochemical purity (≥95%)
  • • Free Iodine-123 impurity (≤5%)
  • • Radionuclidic impurity Iodine-124 (≤0.3%) — CRITICAL!
  • • Radionuclidic impurity Iodine-125 (≤0.1%)
  • • Specific activity (≥100 GBq/μmol)
  • • pH, endotoxins, sterility, residual ethanol
  • ⚠️ CRITICAL: I-124 impurity >0.3% is unacceptable! I-124 emits positrons and high-energy gamma rays, significantly increasing patient dose and degrading image quality (noise).
  • Free iodine accumulates in the thyroid and stomach, creating artifacts.
  • BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore
  • Example (sterility: 0=sterile, 1=contaminated, appearance: 0=normal):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥95% — ensures specific binding to DAT.
  • • Free Iodine-123 ≤5% — requires thyroid blocking with potassium iodide prior to administration if impurity is high.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Iodine-123 Ioflupane using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringI123-IOF-2026-001Batch or lot identifier used for traceability.
2RadiochemicalPurityPercentstring98.5Radiochemical purity; confirms the labelled chemical form and binding quality.
3FreeIodine123Percentdecimal1.0Free radionuclide / unbound species; important for non-target uptake and toxicity.
4RadionuclidicPurityI124Percentstring0.1Radionuclidic purity; a critical radiation-safety and impurity parameter.
5RadionuclidicPurityI125Percentstring0.05Radionuclidic purity; a critical radiation-safety and impurity parameter.
6SpecificActivityGBqPerUmoldecimal150.0Radioactivity value used for release, decay or dose-related assessment.
7pHdecimal7.0Solution pH; relevant for stability, compatibility and administration.
8EndotoxinsEUdecimal40.0Bacterial endotoxins; critical for parenteral administration.
9SterilityTestflag / boolean0Sterility result; critical release parameter.
10EthanolPercentdecimal5.0Controlled input parameter used by the deterministic QC rules.
11AppearanceScorestring0Visual appearance / clarity parameter.
BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore
I123-IOF-2026-001,98.5,1.0,0.1,0.05,150.0,7.0,40.0,0,5.0,0
I123-IOF-2026-002,94.0,4.0,0.5,0.08,120.0,7.2,50.0,0,6.0,0

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Iodine-123 Ioflupane, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "iodine123-ioflupane-quality-checker",
  "api": "Iodine-123 Ioflupane",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "I123-IOF-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeIodine123Percent",
      "value": "1.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityI124Percent",
      "value": "0.1",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityI125Percent",
      "value": "0.05",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SpecificActivityGBqPerUmol",
      "value": "150.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "7.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "40.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Neurology QC Suite

QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: radioiodine

I-123, I-124, I-125 and I-131 for diagnostics, therapy, labelling and purity control.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH use case: generators, isotope purity and starting radionuclides

Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open